- MRKR Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
10-Q/A Filing
Marker Therapeutics (MRKR) 10-Q/A2010 Q1 Quarterly report (amended)
Filed: 14 Oct 11, 12:00am
/s/ Denis Corin __________________________________ | |
Denis Corin Chief Financial Officer, Acting Principal Accounting Officer and a director |